Maverix Biomics provides an intuitive, easy-to-use platform that combines proven methods with relevant public and private data, allowing life science researchers to analyze, visualize, interrogate, and manage next generation sequencing data to accelerate exploration and discovery.  We help you scale to handle large volume studies without having to invest in IT infrastructure, to get your science right.

Ready-to-use, carefully constructed pre-configured pipelines for NGS analysis or customer service development.Learn More
Affordable, easy to use NGS analysis platform for any life science researcher.Learn More
Perform context-aware analysis by integrating your data with private and public data sources and surf results in the UCSC Genome Browser.Learn More
Share data and collaborate with colleagues at the next lab bench or around the globe.Learn More

Our customers use the Maverix Analytic Platform for:

  • Biomarker discovery
  • Diagnostics and testing
  • Quality assurance
  • Comparison of different methods
  • Translational research
  • High-throughput analysis

Platform-as-a-Service offerings:

  • WGS DNA-seq variant analysis
  • Exome DNA-seq variant analysis
  • Targeted DNA-seq variant analysis
  • mRNA-seq expression analysis
  • Small RNA-seq expression analysis
  • Exosome RNA-seq expression analysis

 

 

What our customers are saying

Jeanne Loring
Jeanne LoringProfessor of Developmental Neurobiology and Director of the Center of Regenerative Medicine at The Scripps Research Institute
Next generation sequencing is accelerating our efforts in deciphering disease biology. The Maverix Analytic Platform provides valuable analytic tools to help us efficiently decode biological information that will have a positive influence in our understanding of disease pathways and accelerate the ability to safely develop stem cell-based therapies to treat or prolong the life of individuals with debilitating neurological diseases.

Leslie Lyons
Leslie LyonsGilbreath-McLorn Professor for Comparative Medicine at the University of Missouri-Columbia
I am excited about the potential of the 99 Lives Initiative to lead to a better understanding of cat genetics, which ultimately will lead to advances in healthcare. I look forward to Maverix Biomics’ support of this project to ensure its success via accuracy, consistency, and continuity.

Travis Antes
Travis AntesDirector of Product Development at System Biosciences, Inc.
Delivering sequenced exosome data via the Maverix Analytic Platform gives our customers the ability to interactively explore and browse multiple sets of data which allows them to quickly discover new biomarkers that they hadn’t been aware of before.